Back to Search
Start Over
Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis.
- Source :
-
Pharmaceutics . Nov2023, Vol. 15 Issue 11, p2599. 28p. - Publication Year :
- 2023
-
Abstract
- Non-invasive drug delivery across the blood–brain barrier (BBB) represents a significant advancement in treating neurological diseases. The BBB is a tightly packed layer of endothelial cells that shields the brain from harmful substances in the blood, allowing necessary nutrients to pass through. It is a highly selective barrier, which poses a challenge to delivering therapeutic agents into the brain. Several non-invasive procedures and devices have been developed or are currently being investigated to enhance drug delivery across the BBB. This paper presents a review and a prospective analysis of the art and science that address pharmacology, technology, delivery systems, regulatory approval, ethical concerns, and future possibilities. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 19994923
- Volume :
- 15
- Issue :
- 11
- Database :
- Academic Search Index
- Journal :
- Pharmaceutics
- Publication Type :
- Academic Journal
- Accession number :
- 173868785
- Full Text :
- https://doi.org/10.3390/pharmaceutics15112599